![PDF] Bioequivalence study of 30 mg pioglitazone tablets in Thai healthy volunteers. | Semantic Scholar PDF] Bioequivalence study of 30 mg pioglitazone tablets in Thai healthy volunteers. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25e18dc07f478ecfade16b741d6768a6cb3da9b3/3-Table1-1.png)
PDF] Bioequivalence study of 30 mg pioglitazone tablets in Thai healthy volunteers. | Semantic Scholar
![Healthcare | Free Full-Text | Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution Healthcare | Free Full-Text | Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution](https://www.mdpi.com/healthcare/healthcare-10-01392/article_deploy/html/images/healthcare-10-01392-g001.png)
Healthcare | Free Full-Text | Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial | PLOS Medicine
![Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects - ScienceDirect Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383515001446-fx1.jpg)
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects - ScienceDirect
![Switching among branded and generic medication products during ongoing treatment of psychiatric illness | BMJ Innovations Switching among branded and generic medication products during ongoing treatment of psychiatric illness | BMJ Innovations](https://innovations.bmj.com/content/bmjinnov/6/1/39/F1.large.jpg)
Switching among branded and generic medication products during ongoing treatment of psychiatric illness | BMJ Innovations
![Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs | BMC Pharmacology and Toxicology | Full Text Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs | BMC Pharmacology and Toxicology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40360-017-0182-1/MediaObjects/40360_2017_182_Fig8_HTML.gif)
Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs | BMC Pharmacology and Toxicology | Full Text
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administ
![Adjusted Indirect Treatment Comparison of the Bioavailability of WHO‐Prequalified First‐Line Generic Antituberculosis Medicines - Gwaza - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library Adjusted Indirect Treatment Comparison of the Bioavailability of WHO‐Prequalified First‐Line Generic Antituberculosis Medicines - Gwaza - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/9aefab27-b232-495a-85ae-1e321cd2da0d/cptclpt2014144-gra-0001-m.jpg)